Giorgio Treglia1, Ramin Sadeghi2, Salvatore Annunziata3, Filippo Lococo4, Stefano Cafarotti5, Francesco Bertagna6, John O Prior7, Luca Ceriani8, Luca Giovanella8. 1. Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, via Ospedale, 12; 6500; Bellinzona, Switzerland. Electronic address: giorgiomednuc@libero.it. 2. Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 3. Institute of Nuclear Medicine, Catholic University, Rome, Italy. 4. Unit of Thoracic Surgery, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. 5. Thoracic Surgery, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. 6. Chair of Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy. 7. Nuclear Medicine, Lausanne University Hospital, Lausanne, Switzerland. 8. Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, via Ospedale, 12; 6500; Bellinzona, Switzerland.
Abstract
RATIONALE AND OBJECTIVES: To systematically review and meta-analyze published data about the diagnostic accuracy of fluorine-18-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) and PET/computed tomography (CT) in the differential diagnosis between malignant and benign pleural lesions. METHODS AND MATERIALS: A comprehensive literature search of studies published through June 2013 regarding the diagnostic performance of (18)F-FDG-PET and PET/CT in the differential diagnosis of pleural lesions was carried out. All retrieved studies were reviewed and qualitatively analyzed. Pooled sensitivity, specificity, positive and negative likelihood ratio (LR+ and LR-) and diagnostic odds ratio (DOR) of (18)F-FDG-PET or PET/CT in the differential diagnosis of pleural lesions on a per-patient-based analysis were calculated. The area under the summary receiver operating characteristic curve (AUC) was calculated to measure the accuracy of these methods. Subanalyses considering device used (PET or PET/CT) were performed. RESULTS: Sixteen studies including 745 patients were included in the systematic review. The meta-analysis of 11 selected studies provided the following results: sensitivity 95% (95% confidence interval [95%CI]: 92-97%), specificity 82% (95%CI: 76-88%), LR+ 5.3 (95%CI: 2.4-11.8), LR- 0.09 (95%CI: 0.05-0.14), DOR 74 (95%CI: 34-161). The AUC was 0.95. No significant improvement of the diagnostic accuracy considering PET/CT studies only was found. CONCLUSIONS: (18)F-FDG-PET and PET/CT demonstrated to be accurate diagnostic imaging methods in the differential diagnosis between malignant and benign pleural lesions; nevertheless, possible sources of false-negative and false-positive results should be kept in mind.
RATIONALE AND OBJECTIVES: To systematically review and meta-analyze published data about the diagnostic accuracy of fluorine-18-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) and PET/computed tomography (CT) in the differential diagnosis between malignant and benign pleural lesions. METHODS AND MATERIALS: A comprehensive literature search of studies published through June 2013 regarding the diagnostic performance of (18)F-FDG-PET and PET/CT in the differential diagnosis of pleural lesions was carried out. All retrieved studies were reviewed and qualitatively analyzed. Pooled sensitivity, specificity, positive and negative likelihood ratio (LR+ and LR-) and diagnostic odds ratio (DOR) of (18)F-FDG-PET or PET/CT in the differential diagnosis of pleural lesions on a per-patient-based analysis were calculated. The area under the summary receiver operating characteristic curve (AUC) was calculated to measure the accuracy of these methods. Subanalyses considering device used (PET or PET/CT) were performed. RESULTS: Sixteen studies including 745 patients were included in the systematic review. The meta-analysis of 11 selected studies provided the following results: sensitivity 95% (95% confidence interval [95%CI]: 92-97%), specificity 82% (95%CI: 76-88%), LR+ 5.3 (95%CI: 2.4-11.8), LR- 0.09 (95%CI: 0.05-0.14), DOR 74 (95%CI: 34-161). The AUC was 0.95. No significant improvement of the diagnostic accuracy considering PET/CT studies only was found. CONCLUSIONS: (18)F-FDG-PET and PET/CT demonstrated to be accurate diagnostic imaging methods in the differential diagnosis between malignant and benign pleural lesions; nevertheless, possible sources of false-negative and false-positive results should be kept in mind.
Authors: Amandine Crombé; Nicolas Alberti; Nicolas Villard; Frank Pilleul; Xavier Buy; François Le Loarer; Michèle Kind Journal: Eur Radiol Date: 2019-02-14 Impact factor: 5.315
Authors: Simon Reuter; Dennis Lindgaard; Christian Laursen; Barbara Malene Fischer; Paul Frost Clementsen; Uffe Bodtger Journal: J Thorac Dis Date: 2019-04 Impact factor: 2.895
Authors: Selina Tsim; Catherine A Humphreys; Gordon W Cowell; David B Stobo; Colin Noble; Rosemary Woodward; Caroline A Kelly; Laura Alexander; John E Foster; Craig Dick; Kevin G Blyth Journal: Lung Cancer Date: 2018-02-03 Impact factor: 5.705
Authors: Duneesha de Fonseka; Wendy Underwood; Louise Stadon; Najib Rahman; Anthony Edey; Chris Rogers; Nick A Maskell Journal: BMJ Open Respir Res Date: 2018-02-19